IL-33 and thymic stromal lymphopoietin (TSLP) further amplify these responses by promoting the release of type 2 cytokines and enhancing IgE production, a hallmark of allergic asthma (Calderon et al., 2023; Stanbery et al., 2022). The gene discussed is IGHE; the disease is allergic asthma.